Dabur India Ltd., one of the most respected names in the Indian FMCG sector, has posted a weak performance for the fourth quarter of fiscal year 2025. The company's consolidated net profit has dropped by 8.4% year-on-year, falling to ₹320.13 crore from ₹349.53 crore in the same quarter of the previous year. This fall comes despite a slight increase in revenue, highlighting the ongoing pressure on margins and overall business performance.
The fourth quarter has been particularly challenging due to sluggish demand, especially in urban areas. Additionally, a milder winter season has affected the sale of healthcare products, which form a significant part of Dabur's portfolio. This combination of soft demand and seasonal impact has led to a disappointing end to the financial year.
Revenue from operations grew slightly by 0.5% year-on-year to ₹2,830 crore in Q4 FY25. However, this modest growth was not enough to support profitability. Dabur's EBITDA — which is a measure of operational profitability — dropped by 8.6% to ₹426.8 crore. Moreover, the EBITDA margin, a key profitability indicator, declined from 16.6% in the same quarter last year to 15.1% this quarter.
These figures point to increasing cost pressures and the inability to fully pass on input costs to consumers due to weak demand and intense competition.
Dabur's business is divided into several segments, and each has shown mixed results in the fourth quarter:
Healthcare Segment: Revenue from this segment fell by 4.7% compared to the previous year. This was primarily due to a mild winter, which reduced the need for seasonal healthcare products like cold and cough remedies.
Home and Personal Care Segment: This segment saw a 3.3% decline in revenue. Urban consumption remained soft, and this segment also faced increased competition from other brands offering similar products at aggressive pricing.
Beverages Segment: The performance of beverages was weak, with a 9.2% drop in revenue. The company pointed to poor seasonal demand and a high base in the previous year as contributing factors.
Food Segment: One bright spot for Dabur was its food portfolio, which grew by 14% year-on-year. This growth was driven by strong demand for the Real juice brand and other food products. It shows that certain product categories continue to perform well even in a tough market.
To address these challenges, Dabur has announced several strategies aimed at improving performance in the coming quarters:
Dabur plans to phase out several underperforming products. These include Vedic tea, Dabur Vita health drink, and both adult and baby diaper lines. The company believes that focusing only on profitable and growing products will allow better use of resources and improve margins in the long run.
Recognizing the shift in consumer behavior, Dabur is investing more in e-commerce and quick-commerce channels. These platforms are becoming increasingly important, especially for younger consumers and urban shoppers who prefer fast deliveries and online convenience.
Dabur is also working on making its portfolio premium. This means launching more high-value products in categories like hair care, oral care, and wellness. By offering more premium options, the company hopes to increase its margins and meet the evolving expectations of urban consumers.
As part of its cost-saving efforts, Dabur has reduced its spending on advertising and promotions by 4% compared to the previous year. While this helps in saving costs, it also poses a risk — lower brand visibility could affect future demand if not managed carefully.
To become more responsive to market changes, the company has decided to reduce the gap between strategic reviews. Earlier, these reviews were conducted every four years. Now, they will be conducted every three years. Dabur has also partnered with top consulting firms to reassess its business goals and adjust plans accordingly.
The market reacted negatively to the earnings report. Dabur's stock fell over 4% after the announcement, reflecting investor concerns about the company's near-term growth prospects. The reaction highlights the fact that expectations were higher and the market is unsure if Dabur's cost-cutting and growth plans will pay off quickly enough.
Despite the Q4 setback, the management remains optimistic about the future. The company expects that demand will improve gradually in both rural and urban markets in the coming quarters. Dabur also emphasized its commitment to modernizing its core portfolio and increasing its presence in health and wellness categories. Additionally, the company is open to exploring acquisitions to strengthen its product range in high-growth areas.
Management has set a long-term target of returning to double-digit growth by fiscal year 2028. Achieving this will require consistent performance, successful product innovation, and greater efficiency in operations.
Dabur's Q4 FY25 performance serves as a reminder that even strong, well-established FMCG players are not immune to market pressures. While the company continues to dominate in many categories, changing consumer preferences, economic headwinds, and increased competition are forcing it to rethink strategies.
The decision to cut underperforming products, focus on digital sales, and streamline operations shows that Dabur is serious about adapting to the new business environment. However, the effectiveness of these efforts will become clear only over the next few quarters.
For now, the focus remains on improving profitability, strengthening core segments, and preparing for long-term, sustainable growth. Whether cost-cutting and sharper strategy execution will be enough to lift growth remains to be seen, but Dabur appears committed to making the necessary changes.